{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-042786","form_type":"8-K","ticker":"NEOG","cik":"0000711377","company_name":"NEOGEN CORP","filed_at":"2024-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.735378+00:00","generated_at":"2026-06-04T01:10:53.508765+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neogen reports Q3 revenue up 4.8% to $228.8M but net loss of $2.0M; cuts FY2024 outlook","bullets":["Net loss of $2.0M ($0.01 diluted EPS) vs net income $8.2M ($0.04) a year ago.","Adjusted Net Income $26.4M ($0.12 diluted EPS), flat YoY; Adjusted EBITDA $52.7M (23.0% margin).","Cuts FY2024 revenue guidance to $910-920M and Adj. EBITDA to $210-215M.","Integration of 3M Food Safety creates operational inefficiencies slowing order fulfillment rates.","Cash and investments $168.4M; total debt $900.0M with $150M undrawn credit."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-042786","json":"https://secwatch.observer/filing/0000950170-24-042786.json","markdown":"https://secwatch.observer/filing/0000950170-24-042786.md","text":"https://secwatch.observer/filing/0000950170-24-042786.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711377/000095017024042786/0000950170-24-042786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711377/000095017024042786/neog-20240409.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T01:10:53.508765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bf9bd91206c24558d89195da92132d5cec694838","claim":"NEOGEN CORP reported fiscal 2024 third quarter ended February 29, 2024 results: revenue $228.8 million, net income $(2.0) million; $(0.01) per diluted share, EPS $(0.01) per diluted share. Guidance lowered.","evidence_excerpt":"regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces Third-Quarter 2024 Results • Revenue of $228.8 million. • Net loss of $(2.0) million; $(0.01) per diluted share. • Adjusted Net Income of $26.4 million; $0.12 per diluted share. • Adjusted EBITDA of $52.7 million. • Updating","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017024042786/0000950170-24-042786-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal 2024 third quarter ended February 29, 2024"},{"label":"Revenue","value":"$228.8 million"},{"label":"Net income","value":"$(2.0) million; $(0.01) per diluted share"},{"label":"EPS","value":"$(0.01) per diluted share"},{"label":"Guidance","value":"lowered"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}